Publikationen

Ali, T. T.; Merghani, M.; Al-Azzani, M.; Gatzemeier, L. M.; Hoppert, M.; Kaloyanova, D.; Outeiro, T. F.; Neumann, P.; Popova, B.; Braus, G. H.: Rationally designed peptides inhibit the formation of α-synuclein fibrils and oligomers. European Journal of Medicinal Chemistry 289, 117452 (2025)

Amaral, L.; Martins, M.; Côrte-Real, M.; Outeiro, T. F.; Chaves, S. R.; Rego, A.: The neurotoxicity of pesticides: Implications for Parkinson's disease. Chemosphere 377, 144348 (2025)

Outeiro, T. F.: Alpha-synuclein in Parkinson's disease: the debate that must go on. Parkinsonism & Related Disorders, 107850 (2025)

Koss, D. J.; Todd, O.; Menon, H.; Anderson, Z.; Yang, T.; Findlay, L.; Graham, B.; Palmowski, P.; Porter, A.; Morrice, N. et al.; Walker, L.; Attems, J.; Ghanem, S. S.; El-Agnaf, O.; LeBeau, F. E.; Erskine, D.; Outeiro, T. F.: A reciprocal relationship between markers of genomic DNA damage and alpha-synuclein pathology in dementia with Lewy bodies. Molecular Neurodegeneration 20, 34 (2025)

Laurent, C.; Poncet, G.; Herskovits, T.; Alves de Sousa, R.; Le Corre, L.; Al-Azzani, M.; Koenig, A.; Birman, S.; Outeiro, T. F.; Mansuy, D. et al.; Dairou, J.: Inhibition of the Parkinson’s Disease-Related Protein DJ-1 by Endogenous Neurotoxins of the 1,2,3,4-Tetrahydroisoquinoline Family. ACS Chemical Neuroscience 16 (6), S. 1034 - 1042 (2025)

Flores-León, M.; Outeiro, T. F.: Expanding our understanding of synucleinopathies: proteinopathy, proteinopenia, and lipidopathy. The FEBS Journal (2025)

Coles, N. P.; Elsheikh, S.; Quesnel, A.; Butler, L.; Jennings, C.; Tarzi, C.; Achadu, O. J.; Islam, M.; Kalesh, K.; Occhipinti, A. et al.; Angione, C.; Marles-Wright, J.; Koss, D. J.; Thomas, A. J.; Outeiro, T. F.; Filippou, P. S.; Khundakar, A. A.: Molecular Insights into α-Synuclein Fibrillation: A Raman Spectroscopy and Machine Learning Approach. ACS Chemical Neuroscience 16 (4), S. 687 - 698 (2025)

Outeiro, T. F.; Höglinger, G.; Lang, A. E.; Vieira, T. C. R. G.: Protein misfolding: understanding biology to classify and treat synucleinopathies. Journal of Neural Transmission (2025)

Lang, A. E.; Höglinger, G. U.; Adler, C. H.; Berg, D.; Klein, C.; Outeiro, T. F.; Poewe, W.; Postuma, R.; Stoessl, A. J.: Initial biological classification of Lewy body diseases: No consensus on terminology. Alzheimer's & Dementia 21 (2), e14449 (2025)

da Silva, I. S.; Cardoso, A. R.; Reimer, L.; König, A.; van Riesen, C.; Outeiro, T. F.; Jensen, P. H.; Sales, M. G. F.: α-Synuclein plastic antibody applied to monitor monomeric structures and discriminate aggregated forms in human CSF. Biosensors and Bioelectronics 268, 116880 (2025)

Fonseca-Fonseca, L. A.; Fuentes, N. P.; Sánchez, J. R.; Iglesias, Á. T.; Outeiro, T. F.; Silva, V. D. A. d.; Costa, S. L.; Núñez-Figueredo, Y.: Correlational assessment of the effects of JM-20 in a rat model of parkinsonism. Behavioural Brain Research 476, 115269 (2025)

Coles, N. P.; Elsheikh, S.; Quesnel, A.; Butler, L.; Achadu, O.; Islam, M.; Kalesh, K.; Occhipinti, A.; Angione, C.; Marles-Wright, J. et al.; Koss, D. J.; Thomas, A. J.; Outeiro, T. F.; Filippou, P. S.; Khundakar, A. A.: Alpha-synuclein aggregation induces prominent cellular lipid changes as revealed by Raman spectroscopy and machine learning analysis. Brain Communications 7 (2), fcaf133 (2025)

Brücke, C.; Al-Azzani, M.; Ramalingam, N.; Ramón, M.; Sousa, R. L.; Buratti, F.; Zech, M.; Sicking, K.; Amaral, L.; Gelpi, E. et al.; Chandran, A.; Agarwal, A.; Chaves, S. R.; Fernández, C. O.; Dettmer, U.; Lautenschläger, J.; Zweckstetter, M.; Fernandez Busnadiego, R.; Zimprich, A.; Outeiro, T. F.: A novel alpha-synuclein G14R missense variant is associated with atypical neuropathological features. medRxiv (2025)